Clinical Trial Update: Evaluate the Precision of ABL-101 Perfluorocarbon and Fluorine-19 MRI for the Mapping of Atherosclerotic Plaque Composition and Inflammation in Patients Undergoing Carotid Endarterectomy [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating ABL-101, a perfluorocarbon imaging agent, with Fluorine-19 MRI to map atherosclerotic plaque composition and inflammation in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Artery Disease

Drugs mentioned

• ABL-101 (perfluorocarbon imaging agent)

Snippet

Sponsor: Ruud van Heeswijk | Conditions: Atherosclerotic Disease, Carotid, Carotid Endarterectomy | Phase 2 | Status: NOT_YET_RECRUITING